Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma

por Janku, F., Bauer, S., Shoumariyeh, K., Jones, R.L., Spreafico, A., Jennings, J., Psoinos, C., Meade, J., Ruiz-Soto, R., Chi, P.
Publicado 2022

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

por Greil, C., Engelhardt, M., Ihorst, G., Duque-Afonso, J., Shoumariyeh, K., Bertz, H., Marks, R., Zeiser, R., Duyster, J., Finke, J., Wäsch, R.
Publicado 2020

Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

por Greil, C., Engelhardt, M., Ihorst, G., Duque-Afonso, J., Shoumariyeh, K., Bertz, H., Marks, R., Zeiser, R., Duyster, J., Finke, J., Wäsch, R.
Publicado 2021